Clinical and spectroscopic improvement in HIV-associated cognitive impairment

Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.

1988 • 500 citations

Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia

1999 • 231 citations

Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment

1999 • 190 citations

Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men

1999 • 179 citations

AIDS dementia complex: evaluation with proton MR spectroscopic imaging.

1995 • 147 citations

Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy

1997 • 120 citations

Brain Proton Magnetic Resonance Spectroscopy in HIV-Related Encephalopathy: Identification of Evolving Metabolic Patterns in Relation to Dementia and Therapy

1997 • 81 citations

Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis

1999 • 75 citations

Human Immunodeficiency Virus–Associated Dementia

2000 • 63 citations

Bilateral symmetrical enhancing brainstem lesions: an unusual presentation of primary CNS lymphoma

1999 • 31 citations

Reversible leukoencephalopathy caused by 5-fluorouracil derivatives, presenting as akinetic mutism

1986 • 24 citations

Similar subcortical pattern of cognitive impairment in AIDS patients with and without dementia

2000 • 22 citations